Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Employers Push EHRs into Wider Use

Executive Summary

The goal of developing a nationwide system of electronic healthcare records (EHRs) for most all Americans is moving at a slower pace than some would like. But now, a group of large and influential employers has entered the picture with a plan that seems poised to change the speed and leadership of the endeavor.

You may also be interested in...



Health Care Trends (03/2007): The Case for Pay-for-Performance

The pay-for-performance (P4P) model, which allows hospitals and physicians to be compensated with higher payer reimbursement for providing documented quality care, is becoming a standard practice with a growing number of private insurers, and the federal government wants to use a P4P system for Medicare.

Is the FDA Ready for the Nanotechnology Revolution?

The burgeoning field of nanotechnology is creating hope as well as anxiety in the healthcare industry as researchers look for the best way to use the technology and the FDA grapples to create a policy for regulating products that incorporate the futuristic micro-miniature science. In health care, early focus has been on infection control products.

CMS News is Good for Troubled Markets

There was probably no group more relieved than the makers of implantable cardioverter defibrillators (ICDs) to see the Centers for Medicaid and Medicare Services (CMS) in August drastically modify its proposal to slash hospital reimbursement. The change is as a result of effective lobbying from the medical device community as well as the hospital industry, and is welcome news to all high-end device makers.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT035042

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel